CRAB (Carbapenem-Resistant Acinetobacter baumannii) Treatment Options
Nathan Skorodin PharmD, Nicholas W. Van Hise, PharmD, BCPS
- Case Reports
- September 30, 2021
A 50-Year-Old Woman with Left Foot Mass
Subina Gurung
,
Steven Gitelis
,
Patricia L. Demarais
,
Ira J. Miller
,
John R. Meyer
, and
Nicholas M. Moore
Subina Gurung
Metro Infectious Disease Consultants
Contact Subina Gurung
You can also search for this author inPubMed | Google Scholar |
Steven Gitelis
Rush University Medical Center, Chicago, IL 60612
You can also search for this author inPubMed | Google Scholar |
Patricia L. Demarais
John H. Stroger, Jr. Hospital of Cook County, CHicago, IL 60612, USA
You can also search for this author inPubMed | Google Scholar |
Ira J. Miller
Rush University Medical Center, Chicago, IL 60612, USA
You can also search for this author inPubMed | Google Scholar |
John R. Meyer
Rush University Medical Center, Chicago, IL 60612, USA
You can also search for this author inPubMed | Google Scholar |
Nicholas M. Moore
Rush University Medical Center, Chicago, IL 60612, USA
You can also search for this author inPubMed | Google Scholar |
Subina Gurung
,
Steven Gitelis
,
Patricia L. Demarais
,
Ira J. Miller
,
John R. Meyer
, and
Nicholas M. Moore
Subina Gurung
Metro Infectious Disease Consultants
Contact Subina Gurung
You can also search for this author inPubMed | Google Scholar |
Steven Gitelis
Rush University Medical Center, Chicago, IL 60612
Contact Steven Gitelis
You can also search for this author inPubMed | Google Scholar |
Patricia L. Demarais
Metro Infectious Disease Consultants
Contact Patricia L. Demarais
You can also search for this author inPubMed | Google Scholar |
Ira J. Miller
Metro Infectious Disease Consultants
Contact Ira J. Miller
You can also search for this author inPubMed | Google Scholar |
John R. Meyer
Metro Infectious Disease Consultants
Contact John R. Meyer
You can also search for this author inPubMed | Google Scholar |
Nicholas M. Moore
Metro Infectious Disease Consultants
Contact Nicholas M. Moore
You can also search for this author inPubMed | Google Scholar |
How to Cite: Priv. Pract. Infect. Dis., 2021, 1(1): 4; doi: 10.35995/ppid1010005.
© 2021 Copyright by Author. Licensed as an open access article using a CC BY 4.0 license.
METRICS
Article
Figures/Media
Article
Keywords: Actinomadura; Actinomycetoma; Madura foot
A 50-year-old Nigerian woman presented to the infectious diseases clinic for evaluation of incidental left foot mass. The patient is a healthcare worker who first sought medical attention after a large battery was accidentally dropped on her foot. Her past medical history is significant for removal of a “cyst” in the same area of her foot seven years ago in Nigeria, after presenting with progressive swelling. Aside from mild swelling and discomfort while wearing tight fitted shoes, she remained asymptomatic until the day of battery trauma. Following her accident, she was seen by an orthopedic surgeon for severe left foot pain and swelling. Magnetic Resonance Imaging (MRI) of the left foot revealed a 1.8 × 3.4 × 4.4 cm infiltrative multicystic mass along the dorsal aspect of the fourth metatarsophalangeal joint that was encasing the overlying extensor tendon (Figure 1). The patient underwent open biopsy of the mass which revealed granulation tissue with evidence of acute and chronic inflammation on histology; Gomori Methenamine-Silver and Fite stains did not show any microorganisms, but sulfur granules were present (Figure 2A). Fungal culture plated onto Sabouraud Dextrose agar had organism growth after 16 days of incubation at 30 °C in ambient air (Figure 2B). Additional staining with Kinyoun and modified Kinyoun staining showed non-acid fast filamentous branching bacilli (Figure 3).
Figure 1. Magnetic resonance imaging (MRI) findings. (A) Coronal T2-weighted MRI image revealing an infiltrative multi-cystic mass along the dorsal aspect for the fourth metatarsophalangeal joint. (B) Axial view T2-weighted MRI image with ‘dot-in-a-circle’ sign as shown with the white arrow.
Figure 2. (A) Hematoxylin and eosin stain showing presence of sulfur granules as shown in red rectangular area. Magnification 200×. (B) Figure showing colony morphology in fungal culture with Sabouraud Dextrose agar.
Diagnosis: Actinomycetoma with Actinomadura species
Actinomycetoma is caused by microorganisms of the order Actinomycetales, which includes Nocardia, Actinomadura and Streptomyces species [1]. Actinomadura species are aerobic slow-growing Gram-positive filamentous bacteria found in soil. These organisms are most commonly encountered in the tropical and subtropical regions. Infection with Actinomadura species usually develops after traumatic inoculation of the skin and spread through draining lymphatics. Chronic, progressive granulomatous infections and sinus tracts may form in the subcutaneous tissue of the lower extremities and feet [1,2]. Within the sinus tracts, the bacteria aggregate into granules and evade the innate immune system’s attempts to engulf and inactivate these organisms [1]. In immunocompromised hosts, opportunistic disseminated infection can also occur [3].
Diagnosis of Actinomadura mycetoma is often delayed due to its indolent and chronic course and can often be mistaken for malignancy. The organism can be identified by direct examination as macroscopic granules may be seen with the naked eye. Grains produced by Actinomadura madurae are white, yellow, or cream colored, whereas grains from Actinomadura pelletieri are red [1,4]. The bacteria can be cultured in Lowenstein-Jensen medium or Sabouraud dextrose agar at room temperature. Histopathologic section with hematoxylin-eosin stain can detect grains with a surrounding cluster of neutrophils (Figure 2A). Kinyoun and modified Kinyoun stains are both negative for acid-fastness and demonstrate thin filamentous branching bacilli (Figure 3). Polymerase chain reaction detection and sequencing of 16S rRNA directly from tissue specimens may also aid in diagnosis [5]. Standard radiographic studies such as plain film X-ray can reveal bony involvement such as periosteal erosion and changes consistent with osteomyelitis [1]. A ‘dot in a circle sign’ is usually a characteristic MRI finding seen with this chronic infection (Figure 1) which is described as a sign of a small round- to oval shaped T2-weighted hyperintense lesion with surrounding low-signal intensity and a central low-signal dot [6].
Long term antibiotics is the recommended treatment for chronic actinomycetoma infection. Trimethoprim-sulfamethoxazole (TMP-SMX) is the treatment of choice with an estimated cure rate of 60 percent for uncomplicated cases [7]. Other antibiotic options may include aminoglycosides (streptomycin, amikacin), carbapenems (meropenem, imipenem), dapsone, quinolones, amoxicillin-clavulanic acid, and tetracyclines based upon susceptibilities [7,8]. Antimicrobial susceptibility testing for Actinomadura spp. is not routinely performed in most microbiology labs. In a study of 42 isolates of Actinomadura madurae species referred to the Centers for Disease Control and Prevention, there was no resistance to amikacin, ceftriaxone or imipenem, and 87 percent susceptibility to TMP-SMX alone [9]. Linezolid can be another potential treatment option for those who do not respond to conventional treatment regimens with significant in vitro activity against Actinomadurae spp. and Nocardia spp. [10]. Osteoarticular involvement and disseminated cases may require combination therapy; successful treatment has been described with TMP-SMX and amikacin [7]. Surgery can often be avoided with better prognosis in patients with early diagnosis with appropriate medical management and effective antimicrobial therapy [8]. In developing countries with higher disease prevalence, proper footwear can help prevent direct inoculation of microorganisms.
In our patient, Actinomadura species was identified from the fungal tissue culture after four weeks of incubation and susceptibility results were available after additional three weeks. She was started on oral amoxicillin-clavulanic acid 500 mg three times a day and doxycycline 100 mg two times a day for an anticipated duration of six to twelve months. Rifampin was also added for suspected in vitro activity [7,11] and dual treatment of latent Mycobacterium tuberculosis complex infection. Four weeks after starting antibiotic therapy, she had significant improvement of her symptoms with reduced swelling of the foot.
Funding
There is no relevant funding.
Conflicts of Interest
The authors have no reported conflicts of interest.
References
- Hospenthal, D.R. Agents of Mycetoma. In Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 9th ed.; Bennett, J.E., Dolin, R., Blaser, M.J., Eds.; Elsevier: Philadelphia, PA, USA, 2020. [Google Scholar]
- Rosenberg, A.E.; Kattapuram, S.V.; Nielsen, G.P. Infection of Bone. In Diagnostic Pathology of Infectious Disease, 2nd ed.; Kradin, R.L., Ed.; Elsevier: Philadelphia, PA, USA, 2018. [Google Scholar]
- McNeil, M.M.; Brown, J.M.; Scalise, G.; Piersimoni, C. Nonmycetomic Actinomadura madurae infection in a patient with AIDS. J. Clin. Microbiol. 1992, 30, 1008–1010. [Google Scholar] [CrossRef] [PubMed]
- Bravo, F.G.; Arenas, R.; Sigall, D.A. Actinomycosis, Nocardiosis, and Actinomycetoma. In Fitzpatrick’s Dermatology, 9th ed.; McGraw-Hill: New York, NY, USA, 2019. [Google Scholar]
- Salipante, S.J.; Sengupta, D.J.; Hoogestraat, D.R.; Cummings, L.A.; Bryant, B.H.; Natividad, C.; Thielges, S.; Monsaas, P.W.; Chau, M.; Barbee, L.A.; et al. Molecular Diagnosis of Actinomadura madurae Infection by 16S rRNA Deep Sequencing. J. Clin. Microbiol. 2013, 51, 4262–4265. [Google Scholar] [CrossRef] [PubMed]
- Laohawiriyakamol, T.; Tanutit, P.; Kanjanapradit, K.; Hongsakul, K.; Ehara, S. The “dot-incircle” sign in musculoskeletal mycetoma on magnetic resonance imaging and ultrasonography. SpringerPlus 2014, 3, 671. [Google Scholar] [CrossRef]
- Welsh, O.; Vera-Cabrera, L.; Welsh, E.; Salinas, M.C. Actinomycetoma and advances in its treatment. Clin. Dermatol. 2012, 30, 372–381. [Google Scholar] [CrossRef]
- Tight, R.R.; Bartlett, M.S. Actinomycetoma in the United States. Clin. Infect. Dis. 1981, 3, 1139–1150. [Google Scholar] [CrossRef]
- McNeil, M.M.; Brown, J.M.; Jarvis, W.R.; Ajello, L. Comparison of species distribution and antimicrobial susceptibility of aerobic actinomycetes from clinical specimens. Rev. Infect. Dis. 1990, 12, 778–783. [Google Scholar] [CrossRef]
- Patra, S.; Senthilnathan, G.; Ramam, M.; Arava, S.; Bhari, N. Linezolid: A novel treatment option for the treatment of a non-responsive case of actinomycotic mycetoma. Indian J. Dermatol. Venereol. Leprol. 2021, 87, 455. [Google Scholar] [CrossRef]
- Damle, D.K.; Mahajan, P.M.; Pradhan, S.N.; A Belgaumkar, V.; Gosavi, A.P.; Tolat, S.N.; Gokhale, N.R.; Mhaske, C.B. Modified Welsh regimen: A promising therapy for actinomycetoma. J. Drugs Dermatol. 2008, 7, 853–856. [Google Scholar]
Figures/Media
Figure 1
Magnetic resonance imaging (MRI) findings. (A) Coronal T2-weighted MRI image revealing an infiltrative multi-cystic mass along the dorsal aspect for the fourth metatarsophalangeal joint. (B) Axial view T2-weighted MRI image with ‘dot-in-a-circle’ sign as shown with the white arrow.
Figure 2
(A) Hematoxylin and eosin stain showing presence of sulfur granules as shown in red rectangular area. Magnification 200×. (B) Figure showing colony morphology in fungal culture with Sabouraud Dextrose agar.
Figure 3
Modified Kinyoun stain demonstrating non-acid fast staining bacilli. Magnification 1000×.
Most Viewed
Concomitant Acute Hepatitis E Infection and Autoimmune Hepatitis
Nyal Siddiqi, MD
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis Associated with Acute Necrotizing Soft Tissue Infections: The NASTI-HAT Case Series
Morgan Gilmour, MD
Potential PD-1 inhibitor immune dysregulation as a risk factor for Listeria monocytogenes bacteremia and meningitis
Cherry Au, MD
Predictors of Disease Severity in Patients Hospitalized with COVID-19 during the Omicron Surge of January 2022
Jonathan K. Pinsky, MD
IgG Subclass Deficiency
Russell M. Petrak MD
